Evidence map›Paper›PMID 40708933›Full record

ArticleFrontiers in oncology2025

Escalation, maintenance and abstention in oncology a new study design to identify how individual values of patients impact on the assessment of risks and benefits of novel therapeutic concepts in cases of gynaecological tumors and colorectal cancer: a study protocol.

Susanne Theis, Jülide Senyigit, Britta Büchler, Gesa Kolck, Markus Moehler, Annette Hasenburg, Norbert Paul

Abstract read
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Susanne TheisDepartment of Obstetrics and Gynegology, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
Jülide SenyigitInstitute of History, Philosophy, and Ethics of Medicine, Johannes Gutenberg University Medical Center Mainz, Mainz, Germany.
Britta BüchlerInsitute of Medical Biostatistical, Epidemiology and Informatics (IMBEI), Johannes Gutenberg University Medical Center Mainz, Mainz, Germany.
Gesa KolckDepartment of Internal Medicine I, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
Markus MoehlerDepartment of Internal Medicine I, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
Annette HasenburgDepartment of Obstetrics and Gynegology, University Medical Center of Johannes Gutenberg University Mainz, Mainz, Germany.
Norbert PaulInstitute of History, Philosophy, and Ethics of Medicine, Johannes Gutenberg University Medical Center Mainz, Mainz, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Being diagnosed with cancer is a life-altering event that profoundly reshapes an indivdual's biography, especially in terms of temporality and physicality. Modern treatment approaches, such as maintenance therapy or therapeutic abstinence, often conflict with patients' desire for a radical fight against the disease. Decision-making about therapeutic goals is shaped by the tension between medical-scientific expertise and personal values and experiences, making it particularly challenging to align diverse preferences and norms. This study aims to analyse values in the context of the challenging human experience of cancer. We hypothesise that conventional quantitative measures, including patient-reported outcome measures (PROMs) may be insufficient to fully capture patients' perspective on therapeutic success. To address this, we will conduct semi-structured interviews with individuals diagnosed with gynecological or colorectal cancer. Using a mixed methods approach, we aim to identify patients' values, treatment goals, and expectations. The study's key outcomes include: 1) an ethical analysis of values in the context of cancer experiences 2) a reconstruction of values that shape individual treatment goals and expectations and 3) a comparison between ethical concepts of successful life, patients' situational values, and evidence-based medical preferences. Building on these insights, the study pursues three secondary objectives: 1) developing a strategy for patient-centred adaptation of clinical evaluations of treatment approaches, including escalation, maintenance and abstinence, 2) designing a well-defined clinical framework for therapeutic goal setting, and 3) integrating this framework into medical education, addressing clinical, oncological, ethical and communication competencies.

Indexed as

abstinenceethical conceptsindividual goalsmaintenanceparticipationvalues

Identifiers

PMID40708933
PMCPMC12287738

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.